Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00745355Active Not Recruiting

Quality of Life in Patients With Bladder Cancer

Role: collaborator

NCT01996436Phase 4Terminated

The Intra-arterial Vasospasm Trial

Role: collaborator

NCT06418022Not ApplicableRecruiting

Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning

Role: lead

NCT02725684Completed

Using Genomic Analysis to Guide Individual Treatment in Glioblastoma

Role: collaborator

NCT01605292Not ApplicableCompleted

Radial Artery Access With Ultrasound Trial

Role: collaborator

NCT00629265Not ApplicableCompleted

Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients

Role: collaborator

NCT00494637Not ApplicableTerminated

The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy

Role: lead

All 7 trials loaded